Skip to main content

PSC-Related Blog

A table with a lap top, blue PSC Partners mug, a pen, and a pad of lined paper


March 20, 2017:, an in-depth specialty clinical information website, has featured a guest commentary distinguishing between PSC and PBC following PBC’s name change to Primary Biliary Cholangitis. The commentary was co-authored by Ricky Safer, CEO of PSC Partners, and Martine Walmsley, Chair of Trustees for PSC Support, and highlights the importance of understanding the differences between these two rare autoimmune bile duct diseases. The full text of the commentary can be found here:

Complete your profile and join PSC Partners Seeking a Cure in advancing PSC research towards a cure. Find information about clinical trials.